Gilbert Halley E
SEC CIK 1601360 · EDGAR
BoughtSold
Most active insiders at PCVX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PICKERING GRANT | CEO, Dir | — | $3.63M |
| 2 | GUGGENHIME ANDREW | Pres AND CFO | — | $1.64M |
| 3 | Wassil Jim | EVP, COO, Chief Scientific Ofc | — | $1.43M |
| 4 | Dhaliwal Harpreet S. | Chief Technical Ops Off | — | $1.39M |
| 5 | Cowan Elvia | SVP, Fin | — | $988.6K |
| 6 | Jodar Luis | Chief Medical Off | — | — |
| 7 | Lee Jacks | Dir | — | — |
| 8 | Loxam Teri | Dir | — | — |
| 9 | Furey John | Dir | — | — |
| 10 | Paya Carlos V | Dir | — | — |
| 11 | Gilbert Halley E | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-16 16:18 | 2026-06-15 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +2,265 | 12.5K | +22% | $0 |
| D | 2026-06-09 21:20 | 2026-06-05 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +5,778 | 27.9K | +26% | $0 |
| D | 2025-11-21 | 2025-11-20 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | S - Sale+OE | $27.55 | -16.5K | 22.1K | -43% | -$455.5K |
| D | 2025-11-21 | 2025-11-20 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | M - OptEx | $7.51 | +12.2K | 38.7K | +46% | +$91.8K |
| D | 2025-06-16 | 2025-06-12 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +3,041 | 10.2K | +42% | $0 |
| D | 2025-06-16 | 2025-06-12 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +7,609 | 26.4K | +40% | $0 |
| D | 2024-06-18 | 2024-06-14 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +10.1K | 18.8K | +117% | $0 |
| D | 2024-06-10 | 2024-06-06 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +1,550 | 7,175 | +28% | $0 |
| D | 2024-06-05 | 2024-06-03 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | S - Sale+OE | $73.00 | -18.2K | 5,625 | -76% | -$1.33M |
| D | 2024-06-05 | 2024-06-03 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | M - OptEx | $5.35 | +18.2K | 23.8K | +324% | +$97.4K |
| D | 2023-06-15 | 2023-06-13 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +2,500 | 5,625 | +80% | $0 |
| D | 2023-06-02 | 2023-05-31 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +4,375 | 8,687 | +101% | $0 |
| D | 2022-06-03 | 2022-06-01 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +3,125 | 3,125 | New | $0 |
| D | 2022-06-03 | 2022-06-01 | ARQT | Arcutis Biotherapeutics, Inc. | Gilbert Halley E | Dir | A - Grant | $0.00 | +4,312 | 4,312 | New | $0 |
| D | 2022-03-03 | 2022-03-01 | NEO | NEOGENOMICS INC | Gilbert Halley E | CLO | A - Grant | $0.00 | +42.0K | 147.4K | +40% | $0 |
| 2021-12-30 | 2021-12-30 | NEO | NEOGENOMICS INC | Gilbert Halley E | CLO | A - Grant | $0.00 | +45.9K | 105.1K | +77% | $0 | |
| D | 2021-08-19 | 2021-08-17 | NEO | NEOGENOMICS INC | Gilbert Halley E | CLO | A - Grant | $0.00 | +59.2K | 59.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations